Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Factor V Leiden: should all women be screened prior to commencing the contraceptive pill?

Blood reviews - 1 Mar 1999

Walker I D

Abstract excerpt

It has been evident for over 30 years that combined oral contraceptive pills (OCP) increase the risk of venous thromboembolism. Recently, it has been suggested that there is an interaction between combined OCPs and the factor V Leiden mutation with the result that the relative risk of venous thromboembolism (VTE) is higher than expected in women who have this heritable thrombophilic defect using combined oral...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Factor V
Share to Genetic Testing
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Risk Factors

Share to Venous Thrombosis

Source

Identifiers

PMID: 10225605
DOI: 10.1016/s0268-960x(99)90019-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Factor V Leiden: should all women be screened prior to commencing the contraceptive pill?PMID 10225605Read ↗

Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception.Semantic proximity Read ↗

Factor V Leiden: should we screen oral contraceptive users and pregnant women?Semantic proximity Read ↗

[Screening for factor V Leiden mutation in women using combined hormonal contraceptives or hormone replacement therapy].Semantic proximity Read ↗

Screening for factor V Leiden mutation before prescribing combination oral contraceptives.Semantic proximity Read ↗

Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis.Semantic proximity Read ↗

Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism?Semantic proximity Read ↗

[From pill to pill: oral contraception, venous thrombosis and coagulation disorders].Semantic proximity Read ↗

Risk factors for venous thromboembolism in women under combined oral contraceptive. The PILl Genetic RIsk Monitoring (PILGRIM) Study.Semantic proximity Read ↗

Oral contraception in women with mild thrombophilia: what have we learned recently?Semantic proximity Read ↗

Oral contraceptives and screening for factor V Leiden.Semantic proximity Read ↗

Does use of hormonal contraceptives among women with thrombogenic mutations increase their risk of venous thromboembolism? A systematic review.Semantic proximity Read ↗

Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: prevalence of factor V Leiden.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.